The NORwegian Atrial Fibrillation Self-SCREENing
Not Applicable
Recruiting
- Conditions
- Atrial Fibrillation
- Interventions
- Diagnostic Test: Long-term continuous ECG monitoring
- Registration Number
- NCT05914883
- Lead Sponsor
- Oslo University Hospital
- Brief Summary
Atrial fibrillation (AF) is common, increases the risk of mortality, stroke and heart failure, and portending significant burden to patients, societal health and health economy. One of three AF cases are undiagnosed. Several methods for detection of AF exist, but most of them have major limitations and are associated with resource-demanding diagnostic workup in the speciality health care services.
- Detailed Description
This randomized clinical trial will evaluate whether self-screening for AF with the ECG247 patch monitor will reduce AF-related morbidity.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 35000
Inclusion Criteria
- Age ≥65 years and minimum one other risk factor for stroke according to the CHA2DS2-VASc risk score: Age ≥75 years, Diabetes, Heart failure, Hypertension, Previous stroke/TIA and/or Vascular disease
- Informed consent for participation
Exclusion Criteria
- History of AF (self-reported)
- Use of anticoagulation therapy
- Pacemaker/CRT device
- No smart phone
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description ECG screening Long-term continuous ECG monitoring ECG247 is used for continuous screening for 3-7 days
- Primary Outcome Measures
Name Time Method Stroke 5 years percent per year
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Oslo Unvirsity Hospital
🇳🇴Oslo, Norway